6hxf
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Human STK10 bound to a maleimide inhibitor== | ==Human STK10 bound to a maleimide inhibitor== | ||
- | <StructureSection load='6hxf' size='340' side='right' caption='[[6hxf]], [[Resolution|resolution]] 2.09Å' scene=''> | + | <StructureSection load='6hxf' size='340' side='right'caption='[[6hxf]], [[Resolution|resolution]] 2.09Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6hxf]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HXF OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6hxf]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HXF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6HXF FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=R70:3-(2-methoxyphenyl)-4-[[4-(phenylcarbonyl)phenyl]amino]pyrrole-2,5-dione'>R70</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.09Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=R70:3-(2-methoxyphenyl)-4-[[4-(phenylcarbonyl)phenyl]amino]pyrrole-2,5-dione'>R70</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6hxf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hxf OCA], [https://pdbe.org/6hxf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6hxf RCSB], [https://www.ebi.ac.uk/pdbsum/6hxf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6hxf ProSAT]</span></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/STK10_HUMAN STK10_HUMAN] The disease may be caused by mutations affecting the gene represented in this entry.<ref>PMID:16175573</ref> |
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/STK10_HUMAN STK10_HUMAN] Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo.<ref>PMID:11903060</ref> <ref>PMID:12639966</ref> <ref>PMID:19255442</ref> |
+ | |||
+ | ==See Also== | ||
+ | *[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Arrowsmith | + | [[Category: Large Structures]] |
- | [[Category: Bailey | + | [[Category: Arrowsmith C]] |
- | [[Category: Bountra | + | [[Category: Bailey HJ]] |
- | [[Category: Burgess-Brown | + | [[Category: Bountra C]] |
- | + | [[Category: Burgess-Brown NA]] | |
- | [[Category: Edwards | + | [[Category: Edwards AM]] |
- | [[Category: Elkins | + | [[Category: Elkins JM]] |
- | [[Category: Knapp | + | [[Category: Knapp S]] |
- | [[Category: Krojer | + | [[Category: Krojer T]] |
- | [[Category: Pinkas | + | [[Category: Pinkas D]] |
- | [[Category: Salah | + | [[Category: Salah E]] |
- | [[Category: Savitsky | + | [[Category: Savitsky PA]] |
- | [[Category: Serafim | + | [[Category: Serafim RAM]] |
- | [[Category: Sorrell | + | [[Category: Sorrell FJ]] |
- | [[Category: | + | [[Category: Von Delft F]] |
- | + |
Current revision
Human STK10 bound to a maleimide inhibitor
|
Categories: Homo sapiens | Large Structures | Arrowsmith C | Bailey HJ | Bountra C | Burgess-Brown NA | Edwards AM | Elkins JM | Knapp S | Krojer T | Pinkas D | Salah E | Savitsky PA | Serafim RAM | Sorrell FJ | Von Delft F